EE03688B1 - N-[4-(heteroarüülmetüül)fenüül]-heteroarüülamiinid, nende valmistamismeetod ja kasutamine, farmatseutiline kompositsioon ja meetod selle valmistamiseks - Google Patents
N-[4-(heteroarüülmetüül)fenüül]-heteroarüülamiinid, nende valmistamismeetod ja kasutamine, farmatseutiline kompositsioon ja meetod selle valmistamiseksInfo
- Publication number
- EE03688B1 EE03688B1 EE9800437A EE9800437A EE03688B1 EE 03688 B1 EE03688 B1 EE 03688B1 EE 9800437 A EE9800437 A EE 9800437A EE 9800437 A EE9800437 A EE 9800437A EE 03688 B1 EE03688 B1 EE 03688B1
- Authority
- EE
- Estonia
- Prior art keywords
- preparation
- heteroarylamines
- heteroarylmethyl
- phenyl
- pharmaceutical composition
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
- C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
- C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
- C07D513/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Dermatology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP96201781 | 1996-06-27 | ||
| PCT/EP1997/003248 WO1997049704A1 (en) | 1996-06-27 | 1997-06-19 | N-[4-(heteroarylmethyl)phenyl]-heteroarylamines |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| EE9800437A EE9800437A (et) | 1999-06-15 |
| EE03688B1 true EE03688B1 (et) | 2002-04-15 |
Family
ID=8224119
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| EE9800437A EE03688B1 (et) | 1996-06-27 | 1997-06-19 | N-[4-(heteroarüülmetüül)fenüül]-heteroarüülamiinid, nende valmistamismeetod ja kasutamine, farmatseutiline kompositsioon ja meetod selle valmistamiseks |
Country Status (33)
| Country | Link |
|---|---|
| US (5) | US6124330A (xx) |
| EP (1) | EP0907650B1 (xx) |
| JP (1) | JP3404749B2 (xx) |
| KR (1) | KR100365312B1 (xx) |
| CN (1) | CN1102593C (xx) |
| AR (1) | AR007626A1 (xx) |
| AT (1) | ATE229019T1 (xx) |
| AU (1) | AU711575B2 (xx) |
| BG (1) | BG63545B1 (xx) |
| BR (1) | BR9710002A (xx) |
| CA (1) | CA2258165C (xx) |
| CZ (1) | CZ297769B6 (xx) |
| DE (1) | DE69717627T2 (xx) |
| DK (1) | DK0907650T3 (xx) |
| EE (1) | EE03688B1 (xx) |
| ES (1) | ES2188957T3 (xx) |
| HK (1) | HK1018458A1 (xx) |
| HU (1) | HU223093B1 (xx) |
| ID (1) | ID17275A (xx) |
| IL (1) | IL127740A (xx) |
| MY (1) | MY116917A (xx) |
| NO (1) | NO312102B1 (xx) |
| NZ (1) | NZ333382A (xx) |
| PL (1) | PL201704B1 (xx) |
| PT (1) | PT907650E (xx) |
| RU (1) | RU2190611C2 (xx) |
| SI (1) | SI0907650T1 (xx) |
| SK (1) | SK282769B6 (xx) |
| TR (1) | TR199802709T2 (xx) |
| TW (1) | TW490464B (xx) |
| UA (1) | UA53649C2 (xx) |
| WO (1) | WO1997049704A1 (xx) |
| ZA (1) | ZA975698B (xx) |
Families Citing this family (34)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| UA53649C2 (uk) * | 1996-06-27 | 2003-02-17 | Янссен Фармацевтика Н.В. | N-[4-(гетероарилметил)феніл]гетероариламіни, композиція на їх основі та спосіб її одержання, спосіб одержання сполук (варіанти) |
| WO1999029674A1 (en) | 1997-12-11 | 1999-06-17 | Janssen Pharmaceutica N.V. | Retinoic acid mimetic anilides |
| US6833373B1 (en) | 1998-12-23 | 2004-12-21 | G.D. Searle & Co. | Method of using an integrin antagonist and one or more antineoplastic agents as a combination therapy in the treatment of neoplasia |
| DE19951701A1 (de) | 1999-10-27 | 2001-05-03 | Aventis Pharma Gmbh | Verwendung von 2-Imidazolyl-substituierten Carbinolen zur Herstellung eines Medikaments zur Behandlung oder Prophylaxe von durch ischämischen Zuständen bewirkten Krankheiten |
| AU2003223672A1 (en) * | 2002-04-17 | 2003-11-03 | Tyco Healthcare Group Lp | Method and apparatus for anastomosis including an expandable anchor |
| ATE503483T1 (de) | 2002-10-30 | 2011-04-15 | Merck Sharp & Dohme | Hemmer der akt aktivität |
| WO2004096130A2 (en) | 2003-04-24 | 2004-11-11 | Merck & Co., Inc. | Inhibitors of akt activity |
| WO2006074147A2 (en) | 2005-01-03 | 2006-07-13 | Myriad Genetics, Inc. | Nitrogen containing bicyclic compounds and therapeutical use thereof |
| CN1984660B (zh) | 2003-07-03 | 2010-12-15 | 美瑞德生物工程公司 | 作为天冬氨酸特异性半胱氨酸蛋白酶活化剂和细胞程序死亡诱导剂的4-芳基氨基-喹唑啉 |
| US8309562B2 (en) * | 2003-07-03 | 2012-11-13 | Myrexis, Inc. | Compounds and therapeutical use thereof |
| DE10337942A1 (de) * | 2003-08-18 | 2005-03-17 | Merck Patent Gmbh | Aminobenzimidazolderivate |
| BRPI0516950A (pt) * | 2004-09-24 | 2008-09-30 | Allergan Inc | 4-(metila cìclica condensada)-imidazol-2-tionas atuando como agonistas adrenérgicos alfa2 |
| CA2581828A1 (en) * | 2004-09-24 | 2006-04-06 | Allergan, Inc. | 4-(heteroaryl-methyl and substituted heteroaryl-methyl)-imidazole-2-thiones acting as alpha2 adrenergic agonists |
| CA2581579A1 (en) | 2004-09-24 | 2006-04-06 | Allergan, Inc. | 4-(phenylmethyl and substituted phenylmethyl)-imidazole-2-thiones acting as specific alpha2 adrenergic agonists |
| CN101044120B (zh) * | 2004-09-28 | 2011-06-15 | 阿勒根公司 | 用作特异性或选择性α2肾上腺素能激动剂的未取代和取代的4-苄基-1,3-二氢-咪唑-2-硫酮及其使用方法 |
| US8258145B2 (en) * | 2005-01-03 | 2012-09-04 | Myrexis, Inc. | Method of treating brain cancer |
| US7547782B2 (en) * | 2005-09-30 | 2009-06-16 | Bristol-Myers Squibb Company | Met kinase inhibitors |
| CN101400261B (zh) * | 2006-01-17 | 2013-07-10 | 斯蒂菲尔实验室公司 | 使用***化合物治疗炎症异常 |
| WO2008049027A1 (en) * | 2006-10-17 | 2008-04-24 | Stiefel Laboratories, Inc. | Talarazole metabolites |
| SI2201006T1 (sl) * | 2007-10-18 | 2011-07-29 | Dompe Spa | Derivati (r)-4-(heteroaril)feniletila in farmacevtski sestavki, ki jih vsebujejo |
| GB0811091D0 (en) * | 2008-06-17 | 2008-07-23 | Cancer Rec Tech Ltd | CYP26 Inhibitors |
| US10414760B2 (en) | 2016-11-29 | 2019-09-17 | Angion Biomedica Corp. | Cytochrome P450 inhibitors and uses thereof |
| WO2011153192A2 (en) | 2010-06-01 | 2011-12-08 | Angion Biomedica Corp. | Cytochrome p450 inhibitors and uses thereof |
| KR101108577B1 (ko) * | 2010-07-28 | 2012-01-30 | 국제엘렉트릭코리아 주식회사 | 테이프 히터 |
| PT2730564T (pt) * | 2010-11-19 | 2018-07-24 | Ligand Pharm Inc | Aminas heterocíclicas e suas utilizações |
| WO2013028771A1 (en) | 2011-08-23 | 2013-02-28 | Leong Hwei Xian | Reversing intestinal inflammation by inhibiting retinoic acid metabolism |
| AU2015301891B2 (en) | 2014-08-11 | 2019-12-05 | Angion Biomedica Corporation | Cytochrome P450 inhibitors and uses thereof |
| WO2016109492A1 (en) | 2014-12-31 | 2016-07-07 | Angion Biomedica Corp | Methods and agents for treating disease |
| US10807983B2 (en) | 2015-03-16 | 2020-10-20 | Ligand Pharmaceuticals, Inc. | Imidazo-fused heterocycles and uses thereof |
| CN106588780A (zh) * | 2016-12-15 | 2017-04-26 | 青岛辰达生物科技有限公司 | 一种盐酸右美托咪定中间体的制备工艺 |
| CN106632051A (zh) * | 2016-12-15 | 2017-05-10 | 青岛辰达生物科技有限公司 | 一种盐酸右美托咪定中间体的合成方法 |
| CN106588779A (zh) * | 2016-12-15 | 2017-04-26 | 青岛辰达生物科技有限公司 | 一种合成盐酸右美托咪定中间体的方法 |
| KR20210055340A (ko) | 2019-11-07 | 2021-05-17 | 정화종 | 화물 커버 |
| CN115462347B (zh) * | 2021-08-13 | 2024-07-16 | 广州市妇女儿童医疗中心 | 视黄酸代谢通路在先天性巨结肠疾病中的应用 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NZ221729A (en) * | 1986-09-15 | 1989-07-27 | Janssen Pharmaceutica Nv | Imidazolyl methyl-substituted benzimidazole derivatives and pharmaceutical compositions |
| CA2002859C (en) * | 1988-11-29 | 1998-12-29 | Jean P. F. Van Wauwe | Method of treating epithelial disorders |
| EP0482208B1 (en) | 1990-04-25 | 2000-07-19 | Nissan Chemical Industries Ltd. | Pyridazinone derivative |
| TW321649B (xx) | 1994-11-12 | 1997-12-01 | Zeneca Ltd | |
| US5582832A (en) * | 1995-06-06 | 1996-12-10 | Chesebrough-Pond's Usa Co., Division Of Conopco, Inc. | Compositions for topical application to skin |
| GB9624482D0 (en) | 1995-12-18 | 1997-01-15 | Zeneca Phaema S A | Chemical compounds |
| IL125686A (en) | 1996-02-13 | 2002-11-10 | Zeneca Ltd | Quinazoline derivatives, processes for their preparation, pharmaceutical preparations containing them and their use in the manufacture of a drug with an anti-angiogenic effect and / or an effect of reducing vascular permeability |
| US5731342A (en) * | 1996-02-22 | 1998-03-24 | Eli Lilly And Company | Benzothiophenes, formulations containing same, and methods |
| UA53649C2 (uk) * | 1996-06-27 | 2003-02-17 | Янссен Фармацевтика Н.В. | N-[4-(гетероарилметил)феніл]гетероариламіни, композиція на їх основі та спосіб її одержання, спосіб одержання сполук (варіанти) |
-
1997
- 1997-06-19 UA UA98116146A patent/UA53649C2/uk unknown
- 1997-06-19 EE EE9800437A patent/EE03688B1/xx unknown
- 1997-06-19 JP JP50232198A patent/JP3404749B2/ja not_active Expired - Lifetime
- 1997-06-19 AT AT97930378T patent/ATE229019T1/de active
- 1997-06-19 HU HU9902138A patent/HU223093B1/hu active IP Right Grant
- 1997-06-19 BR BR9710002A patent/BR9710002A/pt not_active IP Right Cessation
- 1997-06-19 RU RU99101902/04A patent/RU2190611C2/ru active
- 1997-06-19 WO PCT/EP1997/003248 patent/WO1997049704A1/en active IP Right Grant
- 1997-06-19 IL IL12774097A patent/IL127740A/en not_active IP Right Cessation
- 1997-06-19 TR TR1998/02709T patent/TR199802709T2/xx unknown
- 1997-06-19 NZ NZ333382A patent/NZ333382A/xx not_active IP Right Cessation
- 1997-06-19 DE DE69717627T patent/DE69717627T2/de not_active Expired - Lifetime
- 1997-06-19 CZ CZ0423198A patent/CZ297769B6/cs not_active IP Right Cessation
- 1997-06-19 ES ES97930378T patent/ES2188957T3/es not_active Expired - Lifetime
- 1997-06-19 CA CA002258165A patent/CA2258165C/en not_active Expired - Lifetime
- 1997-06-19 AU AU34356/97A patent/AU711575B2/en not_active Expired
- 1997-06-19 CN CN97195865A patent/CN1102593C/zh not_active Expired - Lifetime
- 1997-06-19 DK DK97930378T patent/DK0907650T3/da active
- 1997-06-19 KR KR10-1998-0709764A patent/KR100365312B1/ko not_active IP Right Cessation
- 1997-06-19 SI SI9730478T patent/SI0907650T1/xx unknown
- 1997-06-19 PT PT97930378T patent/PT907650E/pt unknown
- 1997-06-19 EP EP97930378A patent/EP0907650B1/en not_active Expired - Lifetime
- 1997-06-19 PL PL330816A patent/PL201704B1/pl unknown
- 1997-06-19 US US09/214,080 patent/US6124330A/en not_active Expired - Lifetime
- 1997-06-19 SK SK1781-98A patent/SK282769B6/sk not_active IP Right Cessation
- 1997-06-23 TW TW086108726A patent/TW490464B/zh not_active IP Right Cessation
- 1997-06-25 MY MYPI97002859A patent/MY116917A/en unknown
- 1997-06-26 AR ARP970102822A patent/AR007626A1/es active IP Right Grant
- 1997-06-26 ID IDP972217A patent/ID17275A/id unknown
- 1997-06-26 ZA ZA975698A patent/ZA975698B/xx unknown
-
1998
- 1998-12-14 BG BG103013A patent/BG63545B1/bg unknown
- 1998-12-21 NO NO19986017A patent/NO312102B1/no not_active IP Right Cessation
-
1999
- 1999-08-16 HK HK99103546A patent/HK1018458A1/xx not_active IP Right Cessation
-
2000
- 2000-07-25 US US09/624,966 patent/US6486187B1/en not_active Expired - Lifetime
-
2002
- 2002-09-10 US US10/238,686 patent/US6833375B2/en not_active Expired - Lifetime
-
2004
- 2004-11-02 US US10/979,362 patent/US7205312B2/en not_active Expired - Fee Related
-
2006
- 2006-12-13 US US11/639,043 patent/US7378433B2/en not_active Expired - Fee Related
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EE03688B1 (et) | N-[4-(heteroarüülmetüül)fenüül]-heteroarüülamiinid, nende valmistamismeetod ja kasutamine, farmatseutiline kompositsioon ja meetod selle valmistamiseks | |
| EE9800136A (et) | Depooravimiks sobiv farmatseutiline kompositsioon, selle valmistamismeetod ja kasutamine | |
| EE9900147A (et) | Oksadiasoolid, nende saamismeetodid ja kasutamine ravimitena | |
| EE9500064A (et) | Asendatud 1H-imidasoolid, nende valmistamismeetodid ja farmatseutilised kompositsioonid | |
| EE03338B1 (et) | Tromboosivastane ravim, selle valmistamise protsess ja kasutamine | |
| EE9900018A (et) | Asendatud püridiinid, nende kasutamine ja farmatseutilised kompositsioonid | |
| BR9708400A (pt) | Composição sua preparação e uso | |
| EE9700363A (et) | Uus anesteseeriva toimega farmatseutiline segu | |
| EE200300236A (et) | 1,2-difenüülasetidinoonid, nende kasutamine, ravim ja selle valmistamismeetod | |
| EE9700310A (et) | N-propargüül-1-aminoindaani R-enantiomeeri, selle soolade ja kompositsioonide kasutamine | |
| EE200000225A (et) | Arüüloksüalküüldialküülamiinid, nende valmistamismeetodid ja farmatseutiline kompositsioon | |
| EE200000596A (et) | Tienüülasolüülalkoksüetaanamiinderivaadid, nende ja nende soolade valmistamismeetod ja kasutamine, farmatseutiline kompositsioon ja kasutamine ning vaheühend ja selle valmistamismeetod | |
| KR100547921B1 (ko) | 설폰아미드-치환된크로만,이의제조방법및이를포함하는약제학적조성물 | |
| FI962908A (fi) | Mikrobinvastainen koostumus, sen valmistusmenetelmä ja sen käyttö | |
| EE04717B1 (et) | Indolüülpiperidiinühendid, nende valmistamismeetod, kompositsioon ja nende kasutamine | |
| EE9900112A (et) | 2-tsüanoiminoimidasooli derivaadid, nende valmistamismeetod, kasutamine ja farmatseutilised kompositsioonid | |
| EE200000226A (et) | 3,6-poolketaalid 9a-asaliidide klassist, nende valmistamismeetod ja farmatseutiline kompositsioon | |
| EE200100314A (et) | Meetod farmatseutilise kompositsiooni valmistamiseks, farmatseutiline kompositsioon ja selle kasutamine | |
| EE9800200A (et) | Bensoüülguanidiini derivaadid, nende valmistamismeetod, kasutamine ja farmatseutiline kompositsioon | |
| EE200000099A (et) | Antimükootiline kompositsioon, selle kasutamine ja valmistamismeetod ning antimükootiline toode | |
| EE04346B1 (et) | Asoolid, nende valmistamismeetod, kasutamine ja farmatseutiline kompositsioon | |
| EE03996B1 (et) | Farmatseutilised kompositsioonid, nende valmistamismeetod ja kasutamine | |
| EE04260B1 (et) | Farmatseutiline kompositsioon, selle valmistamisemeetod ja kasutamine | |
| EE03387B1 (et) | Kombineeritud ravimpreparaat, selle kasutamine ja meetod selle valmistamiseks | |
| EE04770B1 (et) | Tritsüklilised delta3-piperidiinid, nende valmistamismeetod, kasutamine, farmatseutiline kompositsioon ja selle valmistamismeetod |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| KB4A | Valid patent at the end of a year |
Effective date: 20021231 |
|
| KB4A | Valid patent at the end of a year |
Effective date: 20031231 |
|
| KB4A | Valid patent at the end of a year |
Effective date: 20041231 |
|
| KB4A | Valid patent at the end of a year |
Effective date: 20051231 |
|
| KB4A | Valid patent at the end of a year |
Effective date: 20061231 |
|
| KB4A | Valid patent at the end of a year |
Effective date: 20071231 |
|
| KB4A | Valid patent at the end of a year |
Effective date: 20081231 |
|
| KB4A | Valid patent at the end of a year |
Effective date: 20091231 |
|
| KB4A | Valid patent at the end of a year |
Effective date: 20101231 |